In conclusion, our integrated computational study provides preliminary evidence suggesting ESR1 as a potential hub linking BaP exposure to gastric cancer risk, possibly via influencing immune features. This identifies ESR1 as a candidate biomarker and reveals a testable hypothesis for future mechanistic investigation.
Wang et al. (Mon,) studied this question.